Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9551 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9551 |
High Similarity |
NPD6166 |
Phase 2 |
0.9551 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9408 |
High Similarity |
NPD1934 |
Approved |
0.9346 |
High Similarity |
NPD2801 |
Approved |
0.925 |
High Similarity |
NPD7054 |
Approved |
0.9221 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9193 |
High Similarity |
NPD7472 |
Approved |
0.9133 |
High Similarity |
NPD1511 |
Approved |
0.9074 |
High Similarity |
NPD7074 |
Phase 3 |
0.9068 |
High Similarity |
NPD3818 |
Discontinued |
0.9038 |
High Similarity |
NPD3817 |
Phase 2 |
0.9018 |
High Similarity |
NPD6797 |
Phase 2 |
0.9013 |
High Similarity |
NPD1512 |
Approved |
0.8981 |
High Similarity |
NPD3882 |
Suspended |
0.8981 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8963 |
High Similarity |
NPD7251 |
Discontinued |
0.8909 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8909 |
High Similarity |
NPD7808 |
Phase 3 |
0.8903 |
High Similarity |
NPD4380 |
Phase 2 |
0.8805 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8457 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8447 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8443 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8438 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8434 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8415 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8355 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD5403 |
Approved |
0.828 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8272 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.816 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8092 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7976 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD943 |
Approved |
0.7962 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7865 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7857 |
Intermediate Similarity |
NPD919 |
Approved |
0.7853 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7806 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7799 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7746 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7705 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD447 |
Suspended |
0.767 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7665 |
Intermediate Similarity |
NPD37 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7228 |
Approved |
0.764 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7633 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7633 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7584 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7561 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7561 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7547 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7547 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7528 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3226 |
Approved |
0.747 |
Intermediate Similarity |
NPD920 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7416 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7358 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6781 |
Approved |
0.729 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7175 |
Intermediate Similarity |
NPD5242 |
Approved |
0.717 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5353 |
Approved |
0.715 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7097 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6386 |
Approved |
0.709 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7056 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7022 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7022 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7012
|
Intermediate Similarity |
NPD4308 |
Phase 3 |